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Prophylactic Phage Therapy in Infant Rabbits Model of cholera
Abstract

A number of 8 phages lytic of V. cholerae O1- biotype-EI-Tor, serotype Inaba
were selected for the formulation of a phage cocktail. A phage cocktail
composed of 8 phages was prepared and showed 100% inhibition of V.
cholerae isolates comparing with a percentage ranged from 0-75% for
every single phage in growth inhibition assay. The potential activity of
phage cocktail of prophylactic therapy for infant rabbits model of cholera
was evaluated through phage retention time and length of phage
prophylaxis studies. Results have been showed that phage cocktail was
potent in the prevention of development of cholera in infant rabbits dosed
with 5 x 109 PFU of phage cocktail in 3, 12 , and 24 hours prior to infection
with V. cholerae. The infant rabbits administered with the prophylactic dose
of the phage cocktail showed no signs of profuse diarrhea and lost ˂10% of
body weight after 20 hours of infection with V. cholerae comparing with the
infant rabbits non-treated with prophylactic phage dose which lost 10-15%
of the bodyweight within 10-14 hours after infection with V. cholerae. It is
concluded that the results of the animal models confirmed the ability of
phage therapy for cases of cholera and it is a highly promising alternative
antimicrobial therapy for such cases.
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1. Introduction
Cholera is an acute watery diarrhea that results from
infection of small intestine with Vibrio cholarae that
produce cholera toxin (CT) and resulted in profuse
watery diarrhea, loss of electrolytes and rapid dehydration. This could resulted in hypovolemic shock and
metabolic acidosis [1]. Mortality rate of cholera could
be as huge as 70% in the cases of late rehydration of the
patients. It is estimated that global burden of cholera is
1.4e4.3 million cases with deaths ranging from 21,000
to 143,000 yearly [2]. 34 countries documented
1,227,391 cases with 5654 deaths only in 2017 [3].
Several antibiotics have been used as medication of
cholera such as tetracycline, azithromycin and fluoroquinolones [4]. However, in the last decade, a failure in
treatment of cholera cases was repeatedly documented
due to emergence and spread of drug-resistant Vibrio
cholera [5]. The phenomenon of multi-drug resistance
(MDR) and extensive drug resistance in V. cholera is
attributed to many genetic mechanisms such as plasmids,
transposons and insertion sequences (IS) [6,7].
Phage therapy is the most useful alternative therapy
for treatment of drug-resistant Vibrio cholerae.
Recently, many studies have focused on phage therapy
for treatment of cholera in the animal models [8e11].
The targeted prophylactic therapy for cholera is
recommended for closed institutional settings like
prisons and orphanages, where exposure to certain
pathogen is likely to occur over short period of time.
This targeted prophylactic therapy must be given to all
people, I mean patient s, at the same time immediately
after the first case of infection is recognized [12]. The
prophylactic therapy of phages may be superior over
the use of antibiotics as it is results in no side effects
and unrelated to development of drug-resistance on
targeted bacteria as antibiotics do [13].
This study aimes to formulate a phage cocktail
active in treatment of cholera via selection of potent
lytic phages for isolation Vibrio cholorae O1, and to
evaluate their in vitro and in vivo activity against isolates of V. cholorae.

general public health laboratory in Baghdad. Identification, serotyping and biotyping of V. cholerae isolates
were carried out by using cultural, biochemical, serological and molecular methods in the central public
health laboratory in Baghdad. The culture media for
isolation and selection of V. cholerae included the
TCBS agar (Himedia, India), alkaline peptone water
(Himedia, India) and MacConkey agar (Himedia,
India). The serological tests included rapid immunochromatographic detection (IndianMart, India), antigen
rapid test cassette (Novatest, Italy) and Combo rapid
test for V. cholerae O1/O139 antigen (Liming Bio,
China). The molecular diagnosis was by real time PCR
by the V. cholerae TaqMan probe/primer and control
set (Norgen Biotek, Canada).
2.2. Phages
A number of 8 virulent lytic phages against V.
cholerae O1- biotype- EI-Tor, serotype Inaba isolated
from sewage water were selected for preparation of
phage cocktail and evaluation of their activity in prophylactic therapy of infant rabbits model of cholera.
Those phages were PCV6, PCV8, PCV9, PCV15,
PCV19, PCV20, PCV23 and PCV25 (unpublished
data).
2.3. Phage titration

2. Materials and methods

A single colony of V. cholerae isolate was cultured
in Lauria Bertani broth till development of optical
density (O.D.) (Fisher Scientific, USA) to 0.5. The
Phage titration was calculated by top agarose method.
Briefly, an aliquot of top agarose (3 ml) was dispensed
on plane tubes and equilibrated at 45  C to prevent
solidification. A volume of 10 ml of phage preparation
and 100 ml of host V. cholerae culture (mid-log phase)
were added to tubes. Serial dilutions were made for
each by using the same equilibrated top agarose tubes.
Tubes were cooled and 1 ml of mixture from each tube
was poured on the surface of Lauria Bertani agar. The
plates then cooled and incubated at 37  C for 18 h.
Phage titration was calculated as plaque forming units
(PFU) per milliliter of phage preparation [14].

2.1. Bacteria

2.4. Preparation of phage cocktail

A number of 26 isolates of V. cholera O1- biotypeEI- Tor, serotype Inaba were supplied from central

Each single phage in a phage cocktail was
prepared in the desired concentration in SM buffer
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(SigmaeAldrich, USA). Equal volumes of each phage
preparation were mixed to give the phage cocktail with
equal concentration for each single phage in the
cocktail.
2.5. Growth inhibition assay

2.7. The ethical treatment of the animals
The animal studies were done according to the
recommendations of Committee of the Ethics of Laboratory Experiments of the animals in Ministry of
Higher Education and Scientific Research in Iraq.

Each isolate of V. cholerae was cultured in Lauria
Bertani broth and incubated in a shaker incubator at
37  C under 150 rpm/min for 24 h. A volume 50 ml of
Lauria Bertani broth (2X) was added into each well of
a microtiter plate (flat-bottom 96 micro-titer plate). A
concentration of bacterial culture (2  108 CFU/ml)
was prepared through serial dilution, culture of each
dilution, incubation of plates for 24 h and calculation
through the equation:



No: of colonies X dilution factor
CFU ml ¼
Volume of inoculum cultured

2.8. Phage retention time

A volume 50 ml of bacterial culture was added into
each well, followed by addition of 100 ml of phage
preparation. A volume of 50 ml of filter sterilized 0.1%
TTC (Zellibio, Germany) was dispensed into each
well. The microtiter plate was incubated at 37  C for
24 h and measured at OD 540 nm by microtiter plate
reader (BioTeck, USA). The %inhibition of V. cholerae
isolates by single and cocktail phages was calculated
according to the equation [15]:

2.9. Length of phage prophylaxis


%inhibition ¼ 100

A number of 9 infant rabbits were orogastrically
administered with 3  108 PFU of phage cocktail
diluted in the sodium bicarbonate (2.5%). At intervals
of 3, 12 and 24 h, a number of 3 infant rabbits were
sacrificed and dissected. The intestine of each sacrificed infant rabbit was homogenized in Lauria Bertani
broth supplemented with 20% glycerol and PFU for
each homogenized intestine was calculated by top
agarose method [16].

Length of prophylaxis obtained from administration
of phage cocktail was tested. A number of 9 infant
rabbits were orally administered with 5  109 PFU of
phage cocktail diluted in oral solution of sodium bicarbonate (2.5%). Three hours prior to establishment
of V. cholerae, infant rabbits were injected intra-peritoneally
with-ranitidine-hydrochloride
(SigmaeAldrich, USA) (2 mg per gram body weight) to

The absorbace of controls  The absorbance of treated wells
The absorbace of controls

2.6. Animals
Three days old of New Zealand White infant rabbits
(Biotechnology Research Center Animal House, Nahrin University) of both sexes were used for the animal
models of cholera.


Body weight% ¼ 100



reduce acidity of the stomach. Each animal was dosed
orally with 5  108 CFU of bacterial pathogen diluted
oral solution of sodium bicarbonate (2.5%) in 3, 12 and
24 h after administration of phage cocktail. Control
group of 3 infant rabbits were not dosed with V.
cholerae to be compared with other groups. Weight of
infant rabbits was recorded in the beginning and in the
end of the experiment to calculate the percent body
weight as below:

body weight at the end of the experiment
body weight in the beginning of the experiment
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The animals were sacrificed from 10 to-20 h according to percent body weight. Infant rabbits losing
10 to-15% of their body weight were sacrificed from
12 to-14 h, whereas those losing ˂10% of body weight
were sacrificed 20 h post infection.
The intestines of dissected animals were homogenized in Lauria Bertani broth containing 20% glycerol,
serially diluted and plated on Lauria Bertani agar containing 100 mg/ml streptomycin to calculate CFU
per intestine. For extraction of phages from homogenates of intestine, a portion of homogenate was treated
with chloroform and centrifuged as described previously. The PFU per each intestine was determined by
top agarose method [16].
3. Results
3.1. Phage cocktail
The 8 phages were formulated in a cocktail and
tested versus each of the following single phage of
PCV6, PCV8, PCV9, PCV15, PCV19, PCV20, PCV23
and PCV25 in growth inhibition assay. Results of
growth inhibition assay for activity of each one of the 8
single phages and phage cocktail against the 26 isolates
of V. cholerae O1 have showed that %inhibition of
single phages ranged from 0 to 75%, whereas those for
phage cocktail was 100%. Fig. 1 showed the growth
inhibition assay for PVC15 and phage cocktail against
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13 isolates of V. cholerae O1- biotype- EI- Tor, serotype Inaba.
3.2. Phage retention time
The study of phage retention time in the intestine of
the infant rabbits showed drop in number of phages in
a cocktail administered orally from 3  108 PFU to an
average of 64.33 million PFU, 23 million PFU and
9.66 million PFU after 3, 12 and 24 h, respectively
(Fig. 2).
3.3. Length of phage prophylaxis
The study of phage prophylaxis showed that the oral
administration of V. cholerae 3 h after prophylaxis by
phage cocktail resulted in 100% eradication of bacteria
from infant rabbits intestine, whereas oral administration of V. cholerae 12 and 24 h after prophylaxis with
phage cocktail resulted in same result with an exception of survival for only as few as an average of 233.33
and 533.33 CFU/intestine, respectively (Fig. 3).
Plaque forming units (PFU) were calculated in homogenates of sacrificed infant rabbits infected with V.
cholerae in 3, 12 and 24 h after prophylaxis with phage
cocktail. Results also showed the presence of large
numbers of phage particles in homogenates of intestines owing to continuous lysis of V. cholerae in the
presence of phage cocktail. The PFU were recovered

Fig. 1. The %inhibition for the phage PVC15 versus the 8 phages cocktail on 13 V. cholerae isolates by growth inhibition assay.
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Fig. 2. The account of phages in infant rabbits intestine homogenates after 3, 12 and 24 h of oral administration of 3  108 PFU. Each column
represents one infant rabbit.

from homogenates of intestines in an average of
7.66  109, 5.16  109 and 3.26  109 after 3, 12 and
24 h of prophylaxis of infant rabbits with 5  109 PFU
of phage cocktail (Fig. 4).
4. Discussion
The 8 lytic phages for V. cholerae had narrow-host
spectrum and showed 0e75% activity against isolates
of V. cholerae in growth inhibition assay. No single

phage showed broad-spectrum activity against all V.
cholerae isolates and the most potent lytic phages was
PVC15 that showed lytic activity for only 65% of
isolates. The 8 phages cocktail showed 100%inhibition
to all V. cholerae isolates through growth inhibition
assay, whereas phage PVC15 showed %inhibition
ranged from 0 to 75% against tested V. cholerae isolates. Host-range of phages is determined owing to
phage adsorption to certain receptors on bacterial cell
surface, especially Lipopolysaccharides (LPS) [17].

Fig. 3. The account of V. cholerae in infant rabbits intestine homogenates after 3, 12 and 24 h of oral administration of 3  108 PFU with the
positive control not administered with phage cocktail. Each column represents one infant rabbit.
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Fig. 4. The account of phages in infant rabbits intestine homogenates after 3, 12 and 24 h of oral administration of 3  108 PFU. Each column
represents one infant rabbit.

The adsorbed phages to S (smooth)-type LPS exerts
very narrow-host range owing to high variation of Oantigen even within the same bacterial species,
whereas phage adsorbed to R (rough)-type LPS exerts
broader-host range due to conservative composition of
the core of LPS in different genera and species of the
Gram negative bacteria species and genera of Gramnegative bacteria [18]. Some phages adsorbed both Stype and R-type of LPS [17]. The 8 phages selected for
the formulation of phage cocktail had very narrow-host
range that mostly attributed to their adherence to Stype LPS on V. cholerae.
Phages have the ability to adsorb to different receptors on bacterial cell surface as LPS, LPS- protein
complex, Outer membrane proteins (OMPs), selective
transport protein (s) and enzymes localized on outer
membrane [17e20]. The broad-host range of the 8
phages cocktail may be attributed to combinational
properties of phages included in the cocktail to adsorb
to various receptors on cell surface of V. cholerae that
guaranteed availability of one phage or more than one
phage, in a cocktail, capable of adsorption on surface
of target bacterium, whereas each single phage may be
failed to adsorb to certain bacteria owing to incapability for adsorption to any receptor on bacterial surface [21e26].
The infant rabbit model of cholera confirmed the
ability of phages in prophylactic prevention of development of cholera in animals administered high concentration of V. cholerae. The animals administered

with prophylactic dose of phage cocktail lost ˂10% of
body weight after 20 h of administration of high infectious dose of V. cholerae, whereas animals nonadministered with the phage cocktail dose developed
profuse diarrhea and lost 10e15% of body weight
within 10e14 h after taking the infectious dose of V.
cholerae. The prophylactic therapy of phages in
cholera is very important and superior over the use of
antibiotics [12,13].
5. Conclusions
The successfulness of phage cocktail developed in
this study and other in vitro and in vivo previous studies
in treatment of cholera and other bacterial infections
caused by drug-resistant bacteria is highly promising in
the development of pharmaceutical phage cocktails at
commercial level to be available for treatment of
cholera and other bacterial infection in medical
institutions.
6. Recommendations
More global attention must be paid towards development of new phage cocktail specific for treatment of
various non-responsive drug-resistant bacterial infections. It is highly recommended for all health care
institutions worldwide to incorporate units of phage
therapy in their routine work to be an available alternative therapeutic method against drug-resistant
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bacterial infection encountered daily in each medical
care institution.
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